Literature DB >> 2684516

Experience with daily self-administered subcutaneous erythropoietin.

C Granolleras1, B Branger, M C Beau, G Deschodt, B Alsabadani, S Shaldon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2684516     DOI： 10.1159/000417890

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN： 0302-5144            Impact factor:   1.580


× No keyword cloud information.
  6 in total

1.  Treating renal anaemia with recombinant human erythropoietin: practical guidelines and a clinical algorithm.

Authors:  I C Macdougall; R D Hutton; I Cavill; G A Coles; J D Williams
Journal:  BMJ       Date:  1990-03-10

Review 2.  Controversies in determination of epoetin (recombinant human erythropoietin) dosages.

Authors:  P A Abraham; W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-06       Impact factor: 6.447

Review 3.  The use of erythropoietin in renal failure.

Authors:  I C Macdougall; R D Hutton; G A Coles; J D Williams
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

Review 4.  Clinical pharmacokinetics of epoetin (recombinant human erythropoietin).

Authors:  I C Macdougall; D E Roberts; G A Coles; J D Williams
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

5.  Pharmacokinetics of epoetin in haemodialysis patients after subcutaneous administration: influence of chronic treatment.

Authors:  J P Schouten; G Voorhorst; A R Helbing; J W Janssen; P P Diderich; C T Op de Hoek
Journal:  Pharm World Sci       Date:  1993-12-17

Review 6.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.